AYTU BioPharma
AYTU
9 hedge funds and large institutions have $3.9M invested in AYTU BioPharma in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.
365% more capital invested
Capital invested by funds: $839K → $3.9M (+$3.06M)
0.03% more ownership
Funds ownership: 0.06% → 0.09% (+0.03%)
10% less funds holding
Funds holding: 10 → 9 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.37M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$35.6K |
| 3 |
VF
Virtu Financial
New York
|
+$22.2K |
| 4 |
SC
Searle & Co
Greenwich,
Connecticut
|
+$18.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$13.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$408K |
| 2 |
Renaissance Technologies
New York
|
-$75K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$35K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $3.34M | +$2.37M | +9,500 | +1,900% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $159K | – | – | – |
|
|
WC
3
Wexford Capital
West Palm Beach,
Florida
| $149K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $91K | – | – | – |
|
|
5
Acadian Asset Management
Boston,
Massachusetts
| $72K | +$35.6K | +143 | +196% |
|
|
VF
6
Virtu Financial
New York
| $30K | +$22.2K | +89 | New |
|
|
SC
7
Searle & Co
Greenwich,
Connecticut
| $25K | +$18.7K | +75 | New |
|
|
8
Northern Trust
Chicago,
Illinois
| $18K | +$13.2K | +53 | New |
|
9
UBS Group
Zurich,
Switzerland
| $15K | +$11.2K | +45 | New |
|
|
SM
10
Sabby Management
Miami Beach,
Florida
| – | -$408K | -2,575 | Closed |
|
|
11
Renaissance Technologies
New York
| – | -$75K | -476 | Closed |
|
|
12
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$35K | -223 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$22K | -141 | Closed |
|
|
ARTA
14
A.R.T. Advisors
New York
| – | -$19K | -120 | Closed |
|
AYTU Hedge Fund Activity: Q1 2019 in Review
9 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q1 2019, worth a combined $3.9M — up 365% from $839K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of AYTU and 4 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Armistice Capital, adding an estimated $2.37M. The largest seller was Sabby Management, exiting entirely with an estimated $408K sold.
- 9 institutional investors held AYTU BioPharma (AYTU) as of Q1 2019, down from 10 in Q4 2018.
- Funds reported $3.9M of AYTU BioPharma stock for Q1 2019, up 365% quarter-over-quarter.
- 4 funds opened new AYTU BioPharma positions in Q1 2019 and 5 closed out, a net change of -1 holder.
- The largest AYTU BioPharma buyer in Q1 2019 was Armistice Capital, an estimated $2.37M added.
- The largest AYTU BioPharma seller in Q1 2019 was Sabby Management, an estimated $408K sold.
Based on aggregated 13F filings for Q1 2019.